Doris Molina-Henry will be presenting at the Human Amyloid Imaging (HAI) 2025 Conference on Friday, January 17 in San Juan, Puerto Rico.
The HAI Conference brings together leading researchers in the field of human amyloid imaging. Molina-Henry’s presentation, titled “Racial and ethnicity differences in plasma biomarker eligibility prior to amyloid PET imaging in the AHEAD 3-45 Study,” will be held on Friday, January 17th. Her research focuses on inclusion of understudied groups in Alzheimer’s clinical trials including members of disadvantaged socioeconomic background and diverse racial and ethnic populations.
As Molina-Henry notes, “Plasma marker data has unlocked extraordinary opportunities to deepen our understanding and characterization of Alzheimer’s disease across diverse populations. Continually evaluating the relationship of these novel plasma markers to established imaging metrics is critical, especially among understudied groups.”
Registration for HAI 2025 is now open, and we encourage you to follow Molina-Henry to learn more about her research.